Organization
Landos Biopharma
2 clinical trials
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Multicenter Phase 2 Induction Study With Long-Term Extension to Evaluate the Clinical Activity and Safety of Oral NX-13 in Participants w/ Moderate to Severe Ulcerative ColitisStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
A Randomized, Double-blind Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral NX-13 in Active Ulcerative ColitisStatus: Completed, Estimated PCD: 2022-06-17